Current perspectives in percutaneous atrial septal defect closure devices
Open Access
- 1 July 2015
- journal article
- review article
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 8, 297-303
Abstract
In the last decade, percutaneous atrial septal defect (ASD) closure has become the treatment of choice in most clinical presentations of ASD. Percutaneous ASD closure has established procedural safety through operator experience and improved device structure and deliverability. There have also been advances in diagnostic capabilities. Devices have evolved from large bulky meshes to repositionable, minimal residual mesh content that easily endothelializes and conforms well to surrounding structures. Biodegradable technology has been introduced and will be closely watched as a future option. The evolution of ASD closure device usage in the last four decades incorporates development that minimizes a wide range of serious side effects that have been reported over the years. Complications reported in the literature include thrombus formation, air embolization, device embolization, erosions, residual shunts, and nickel hypersensitivity. Modern devices have intermediate to long term data with outcomes that have been favorable. Devices are available in multiple sizes with improved delivery mechanisms to recapture, reposition, and safely close simple and complex ASDs amenable to percutaneous closure. In this review, commonly used devices and deployment procedures are discussed together with a look at devices that show promise for the future.Keywords
This publication has 17 references indexed in Scilit:
- Optimal septum alignment of the Figulla® Flex occluder to the atrial septum in patients with secundum atrial septal defectsEuroIntervention, 2016
- Transcatheter closure of atrial septal defect with the Figulla® ASD Occluder: A comparative study with the Amplatzer® Septal OccluderArchives of Cardiovascular Diseases, 2015
- Device therapy for atrial septal defects in a multicenter cohort: Acute outcomes and adverse eventsCatheterization and Cardiovascular Interventions, 2014
- Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovaleEuroIntervention, 2013
- Bioabsorbable atrial septal occluder for percutaneous closure of atrial septal defect in children.2012
- Tools & Techniques: PFO/ASD closureEuroIntervention, 2011
- Transcatheter Closure of Atrial Septal Defect with Amplatzer Septal Occluder in Adults: Immediate, Short, and Intermediate-Term Results2011
- Results of the U.S. Multicenter Pivotal Study of the HELEX Septal Occluder for Percutaneous Closure of Secundum Atrial Septal DefectsJACC, 2007
- Device Closure Rates of Simple Atrial Septal Defects Optimized by the STARFlex DeviceJACC, 2006
- Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device.Circulation, 1993